Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
ObsEva SA Act Nom (OTC : OBSEF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The company is focused on providing therapeutic solutions for women between the ages of 15 and 49 who suffer from reproductive health conditions that affect their quality of life, ability to conceive or that complicate pregnancy and the health of newborns. The is developing OBE2109 as a novel, oral gonadotropin-releasing hormone, or GnRH, receptor antagonist, for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.
Quote
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1e-05 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0 |
| Volume: | 13,479 |
| Last Trade Date Time: | 06/05/2026 12:21:21 pm |
Stock Data
| Market Cap: | $15,991 |
|---|---|
| Float: | 79,155,715 |
| Insiders Ownership: | N/A |
| Institutions: | 8 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.obseva.com |
| Country: | CH |
| City: | Geneva |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about ObsEva SA Act Nom (OTC: OBSEF).
